Revolution Medicines Inc (NASDAQ: RVMD) on Friday, plunged -1.92% from the previous trading day, before settling in for the closing price of $39.05. Within the past 52 weeks, RVMD’s price has moved between $29.17 and $62.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -27.80% over the last five years. The company achieved an average annual earnings per share of -31.53%. With a float of $161.88 million, this company’s outstanding shares have now reached $186.26 million.
The firm has a total of 534 workers. Let’s measure their productivity. In terms of profitability, gross margin is 45.12%, operating margin of -301.78%, and the pretax margin is -266.93%.
Revolution Medicines Inc (RVMD) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Revolution Medicines Inc is 13.09%, while institutional ownership is 93.62%. The most recent insider transaction that took place on Jun 20 ’25, was worth 75,736. In this transaction General Counsel of this company sold 1,912 shares at a rate of $39.61, taking the stock ownership to the 54,093 shares. Before that another transaction happened on Jun 20 ’25, when Company’s Officer proposed sale 1,912 for $39.93, making the entire transaction worth $76,346.
Revolution Medicines Inc (RVMD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -31.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.61% during the next five years compared to -27.80% drop over the previous five years of trading.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Revolution Medicines Inc (RVMD) is currently performing well based on its current performance indicators. A quick ratio of 13.46 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.00, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -5.01 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Analysing the last 5-days average volume posted by the [Revolution Medicines Inc, RVMD], we can find that recorded value of 1.49 million was lower than the volume posted last year of 1.87 million. As of the previous 9 days, the stock’s Stochastic %D was 70.77%.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 62.97%, which indicates a significant increase from 59.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.19 in the past 14 days, which was lower than the 1.69 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.19, while its 200-day Moving Average is $42.92. Now, the first resistance to watch is $39.19. This is followed by the second major resistance level at $40.09. The third major resistance level sits at $40.55. If the price goes on to break the first support level at $37.83, it is likely to go to the next support level at $37.37. Should the price break the second support level, the third support level stands at $36.47.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
Market capitalization of the company is 7.13 billion based on 186,268K outstanding shares. Right now, sales total 0 K and income totals -600,090 K. The company made 0 K in profit during its latest quarter, and -213,420 K in sales during its previous quarter.
